Bellevue, WA, United States of America

Ramesh Annasaheb Kasar

USPTO Granted Patents = 3 

Average Co-Inventor Count = 9.2

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2016-2017

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ramesh Annasaheb Kasar: Innovator in Antibacterial Agents

Introduction

Ramesh Annasaheb Kasar is a prominent inventor based in Bellevue, WA, known for his significant contributions to the field of antibacterial agents. With a total of three patents to his name, Kasar has demonstrated his dedication to advancing pharmaceutical sciences and tackling bacterial infections.

Latest Patents

Kasar's latest innovations focus on antibacterial compounds, specifically formulations that include compounds of formula (I). These patents not only cover the compounds themselves but also include stereoisomers and pharmaceutically acceptable salts. Furthermore, they encompass pharmaceutical compositions comprising such compounds, methods for treating bacterial infections through their administration, and processes for preparing these compounds. His advancements are crucial in the ongoing battle against bacterial pathogens, representing a significant step forward in medical treatment options.

Career Highlights

Ramesh Annasaheb Kasar is currently employed at Achaogen, Inc., a biotechnology company that focuses on developing therapies for bacterial infections. His work at Achaogen leverages his expertise in pharmaceuticals, aiming to bring effective treatments to market. Throughout his career, he has consistently focused on innovative solutions to complex medical challenges.

Collaborations

Kasar has collaborated with esteemed colleagues in the field, including Brian D Patterson and Qing Lu. These partnerships highlight the collaborative spirit within the scientific community and demonstrate how teamwork can lead to groundbreaking advancements in health science.

Conclusion

Ramesh Annasaheb Kasar is an important figure in the realm of antibacterial agent development. His three patents reflect a commitment to innovation and improvement in infection treatment, making him a valuable contributor to public health. As he continues to work at Achaogen, Inc., the medical community eagerly anticipates his future contributions to the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…